Dr. Andro T. Zangaladze, MD

Dr. Zangaladze practices at Jefferson Health in Marlton, New Jersey.

Dr. Zangaladze's NPI, 1255358602, was assigned on July 15, 2006. Dr. Zangaladze holds Pennsylvania license MD418139.

Dr. Zangaladze's primary practice is Jefferson Health, at 73 N Maple Ave, Marlton, NJ 08053 in Burlington County. The practice phone is (856) 783-1987.

Dr. Zangaladze's primary practice is Jefferson Health in Marlton, New Jersey. Dr. Zangaladze is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Jefferson Health. Dmand AI also links Dr. Zangaladze to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zangaladze practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Zangaladze's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Zangaladze is licensed in Pennsylvania.

CMS data shows 8,934 Medicare services from Dr. Zangaladze across 10 procedure codes in 2024, for 456 Medicare patients. Medicare paid $82,705 for them.

CMS counts 456 Medicare patients who saw Dr. Zangaladze in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zangaladze's median patient age at 65, with 62% women.

In 2024, Dr. Zangaladze wrote 1,578 Medicare Part D claims for 265 patients. 81% of them were for generic drugs. CMS names the drug for 1,362 of them, across 45 drugs with 11 or more claims each, at $295,301 in total drug cost. In 2023, CMS named 617 claims across 21 drugs.

Dr. Zangaladze accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zangaladze as offering telehealth.

Dmand AI links 8 papers to Dr. Zangaladze, published from 2011 to 2020. 2011 was the busiest year, with 4. The most frequent topics are Electroencephalography, Anticonvulsants and Epilepsy. Dr. Zangaladze has published most often in Epilepsy Behav. Dr. Zangaladze's most frequent co-authors are Maromi Nei, MD, David Alexander Roshal, DO and Sarah E. Buckingham, MD.

CMS Open Payments shows 527 general payments to Dr. Zangaladze from 33 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Sunovion Pharmaceuticals Inc. paid the most, $123,679.